• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Allakos Inc (NQ: ALLK )

    0.7500 -0.0735 (-8.93%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 269,726
    Open 0.8100
    Bid (Size) 0.7500 (6)
    Ask (Size) 0.7996 (5)
    Prev. Close 0.8235
    Today's Range 0.7500 - 0.8234
    52wk Range 0.7200 - 5.640
    Shares Outstanding 86,560,315
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Allakos Announces Positive Results from its Ongoing Phase 1 Trial of AK006 in Healthy Volunteers, with AK006 Demonstrating High Receptor Occupancy on Mast Cells and a Favorable Safety Profile
    From Allakos Inc.
    Via GlobeNewswire
    Allakos Announces First Patient Dosed in Phase 1 Trial of AK006 in Chronic Spontaneous Urticaria
    From Allakos Inc.
    Via GlobeNewswire

    Performance

    YTD
    -72.63%
    -72.63%
    1 Month
    -35.90%
    -35.90%
    3 Month
    -29.25%
    -29.25%
    6 Month
    -26.47%
    -26.47%
    1 Year
    -84.04%
    -84.04%

    More News

    Read More
    ALLK Stock Earnings: Allakos Meets EPS for Q1 2024
    Via InvestorPlace
    Allakos Provides Business Update and Reports First Quarter 2024 Financial Results
    From Allakos Inc.
    Via GlobeNewswire
    ALLK Stock Earnings: Allakos Misses EPS for Q4 2023
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    3 Biotech Stocks to Dump Before They Go to Zero
    Via InvestorPlace
    Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
    From Allakos Inc.
    Via GlobeNewswire
    Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024
    From Allakos Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition
    From Allakos Inc.
    Via GlobeNewswire
    Netflix To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Gold Down 1%; PNC Financial Posts Upbeat Earnings
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Crude Oil Edges Lower; Morgan Stanley Posts Upbeat Revenue
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Why Is Allakos (ALLK) Stock Down 57% Today?
    Via InvestorPlace
    Trial Setback: Allakos Drops Lead Skin Disorder Candidate, Cuts Workforce By 50%
    Via Benzinga
    Dow Dips 200 Points; Goldman Sachs Earnings Top Views
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Allakos Announces a Restructuring to Focus on Development of AK006
    From Allakos Inc.
    Via GlobeNewswire
    Allakos Announces Phase 2 Lirentelimab Trials in Atopic Dermatitis and Chronic Spontaneous Urticaria Did Not Meet Their Primary Endpoints
    From Allakos Inc.
    Via GlobeNewswire
    Allakos Analyst Turns Bullish, Sees 'Significant Upside' If Study Results Are Positive
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.